ALPA — Alpa Laboratories Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapTurnaround

Annual cashflow statement for Alpa Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	196	157	208	258	174
Depreciation
Non-Cash Items	-96.1	-37.1	-114	-179	-140
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-16.6	-44	-77	82.1	45
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	99.4	89	36.5	183	99.5
Capital Expenditures	-21.9	-11.3	-63.9	-114	-39.5
Purchase of Fixed Assets
Other Investing Cash Flow Items	-134	32.5	-69.5	-9.82	-76
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-156	21.3	-133	-124	-116
Financing Cash Flow Items	-2.19	-2.24	-3.59	-2.32	-2.52
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities	54.4	-37.9	25.8	-54.4	22.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2.27	72.4	-71	5.12	6.16